危重症中循环N-甲酰甲硫氨酸与代谢转变:多队列代谢组学研究
在VITdAL-ICU队列(428例)和RoCI队列(90例)中分析ICU入院时血浆代谢组(分别983种和411种代谢物),VITdAL-ICU另分析第3天和第7天。校正逻辑回归显示,N-甲酰甲硫氨酸丰度最高四分位者28天死亡校正OR在VITdAL-ICU为2.4(95%CI 1.5-4.0,P=0.001),RoCI为5.1(95%CI 1.4-18.7,P=0.015)。两队列共有55种代谢物随N-甲酰甲硫氨酸丰度升高而呈显著差异,表现为短链酰基肉碱、支链氨基酸、犬尿氨酸途径和磷酸戊糖途径代谢物升高。结果提示循环N-甲酰甲硫氨酸促进代谢转变并与死亡率升高相关,涉及线粒体脂肪酸氧化不完全、支链氨基酸代谢增加和磷酸戊糖途径激活。
要点
- ICU入院时N-甲酰甲硫氨酸丰度最高四分位者28天死亡校正OR在VITdAL-ICU为2.4(95%CI 1.5-4.0,P=0.001),在RoCI为5.1(95%CI 1.4-18.7,P=0.015)。
- 随N-甲酰甲硫氨酸丰度升高,两队列共有55种代谢物呈显著差异(经错误发现率校正)。
- N-甲酰甲硫氨酸丰度升高时,两队列均见短链酰基肉碱、支链氨基酸、犬尿氨酸途径和磷酸戊糖途径代谢物升高。
- 作者认为循环N-甲酰甲硫氨酸促进代谢转变,与死亡率升高相关,涉及线粒体脂肪酸氧化不完全、支链氨基酸代谢增加和磷酸戊糖途径激活。
适用人群与场景
- 危重症成人:VITdAL-ICU试验队列428例和布莱根妇女医院危重症登记(RoCI)队列90例。
研究设计与关键结果
- 研究类型:多队列代谢组学研究;VITdAL-ICU队列428例,RoCI队列90例。
- VITdAL-ICU队列分析983种代谢物(ICU入院时、第3天和第7天),RoCI队列分析411种代谢物(ICU入院时)。
- ICU入院时N-甲酰甲硫氨酸丰度最高四分位者28天死亡校正OR:VITdAL-ICU为2.4(95%CI 1.5-4.0,P=0.001),RoCI为5.1(95%CI 1.4-18.7,P=0.015)。
- 校正线性回归显示,随ICU入院时N-甲酰甲硫氨酸丰度升高,55种代谢物在VITdAL-ICU和RoCI两队列均呈显著差异(经错误发现率校正)。
- 随N-甲酰甲硫氨酸丰度升高,两队列均见短链酰基肉碱、支链氨基酸、犬尿氨酸途径和磷酸戊糖途径代谢物升高。
证据类型、等级与局限
- 证据类型:多队列代谢组学研究(VITdAL-ICU试验队列和RoCI队列)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为循环N-甲酰甲硫氨酸促进代谢转变,与死亡率升高相关,涉及线粒体脂肪酸氧化不完全、支链氨基酸代谢增加和磷酸戊糖途径激活。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Cell stress promotes degradation of mitochondria which release danger-associated molecular patterns that are catabolized to N-formylmethionine. We hypothesized that in critically ill adults, the response to N-formylmethionine is associated with increases in metabolomic shift-related metabolites and increases in 28-day mortality.
METHODS: We performed metabolomics analyses on plasma from the 428-subject Correction of Vitamin D Deficiency in Critically Ill Patients trial (VITdAL-ICU) cohort and the 90-subject Brigham and Women's Hospital Registry of Critical Illness (RoCI) cohort. In the VITdAL-ICU cohort, we analyzed 983 metabolites at Intensive Care Unit (ICU) admission, day 3, and 7. In the RoCI cohort, we analyzed 411 metabolites at ICU admission. The association between N-formylmethionine and mortality was determined by adjusted logistic regression. The relationship between individual metabolites and N-formylmethionine abundance was assessed with false discovery rate correction via linear regression, linear mixed-effects, and Gaussian graphical models.
RESULTS: Patients with the top quartile of N-formylmethionine abundance at ICU admission had a significantly higher adjusted odds of 28-day mortality in the VITdAL-ICU (OR, 2.4; 95%CI 1.5-4.0; P = 0.001) and RoCI cohorts (OR, 5.1; 95%CI 1.4-18.7; P = 0.015). Adjusted linear regression shows that with increases in N-formylmethionine abundance at ICU admission, 55 metabolites have significant differences common to both the VITdAL-ICU and RoCI cohorts. With increased N-formylmethionine abundance, both cohorts had elevations in individual short-chain acylcarnitine, branched chain amino acid, kynurenine pathway, and pentose phosphate pathway metabolites.
CONCLUSIONS: The results indicate that circulating N-formylmethionine promotes a metabolic shift with heightened mortality that involves incomplete mitochondrial fatty acid oxidation, increased branched chain amino acid metabolism, and activation of the pentose phosphate pathway.
参考来源
- Sigurdsson MI, Kobayashi H, Amrein K, et al. Circulating N-formylmethionine and metabolic shift in critical illness: a multicohort metabolomics study. Crit Care. 2022. PMID: 36261854. doi:10.1186/s13054-022-04174-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。